Indeed, after efficient pharmacological inhibition of Eg5 in an in vitro ER+/PR+ BC model, a slight inhibition of cell invasion was highlighted and a higher migration inhibition was reported, probably through a modulation of the MMP-9/NF-kB pathway. Here, ESR1 is linked to breast cancer.